An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
复制标题
DOI：
10.1164/rccm.2009-040gl
复制
发表时间：
2011-03-15
影响因子：
24.7
通讯作者：
Schuenemann, Holger J.
中科院分区：
文献类型：
--
作者：
Raghu, Ganesh;Collard, Harold R.;Schuenemann, Holger J.
本文件是关于特发性肺纤维化诊断和治疗的国际循证指南，是美国胸科学会、欧洲呼吸学会、日本呼吸学会和拉丁美洲胸科学会的合作成果。它代表了有关特发性肺纤维化 (IPF) 的当前知识状况，包含定义和流行病学、危险因素、诊断、自然史、分期和预后、治疗以及病程监测等部分。对于诊断和治疗部分，以基于问题的形式应用了务实的 GRADE 循证方法。对于每个诊断和治疗问题，委员会对现有证据的质量进行评分（高、中、低或极低），并提出建议（是或否、强或弱）。建议基于多数票。需要强调的是，临床医生必须花足够的时间与患者讨论患者的价值观和偏好，并决定适当的行动方案。
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.